Global landscape of liver disease burden in 1990–2021

Liver diseases remain a major global contributor to disability-adjusted life years (DALYs). Using Global Burden of Disease 2021 data, we applied a three-tier framework linking total liver diseases to acute hepatitis, cirrhosis, liver cancer, and their main etiologies. In 2021, liver diseases caused 309.72 million new cases, 1.98 million deaths, and 63.53 million DALYs worldwide. Although global age-standardized rates declined, death and DALY rates increased in High-income North America and Australasia, with steatosis- and alcohol-related liver diseases accounting for a growing share of the burden. Independent datasets, including the World Health Organization and Global Cancer Observatory sources, supported these regional patterns. Disease burden showed marked age, sex, and etiological disparities, with metabolic factors rising rapidly. Although overall mortality is projected to decline, liver cancer due to steatohepatitis and hepatoblastoma is projected to rise. These findings highlight persistent regional, demographic, and etiological disparities and the need for targeted public health action.

Authors

Institutions

Publication Details

Journal
iScience
Published
2026-06-26
DOI
https://doi.org/10.1016/j.isci.2026.116406
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Global landscape of liver disease burden in 1990–2021

M Zhang, Weiqiu Jin, Lijie Ma, Qiang Xia
iScience
Liver Disease and Transplantation
article

Global landscape of liver disease burden in 1990–2021

M Zhang, Weiqiu Jin, Lijie Ma, Qiang Xia
article en

Abstract

Liver diseases remain a major global contributor to disability-adjusted life years (DALYs). Using Global Burden of Disease 2021 data, we applied a three-tier framework linking total liver diseases to acute hepatitis, cirrhosis, liver cancer, and their main etiologies. In 2021, liver diseases caused 309.72 million new cases, 1.98 million deaths, and 63.53 million DALYs worldwide. Although global age-standardized rates declined, death and DALY rates increased in High-income North America and Australasia, with steatosis- and alcohol-related liver diseases accounting for a growing share of the burden. Independent datasets, including the World Health Organization and Global Cancer Observatory sources, supported these regional patterns. Disease burden showed marked age, sex, and etiological disparities, with metabolic factors rising rapidly. Although overall mortality is projected to decline, liver cancer due to steatohepatitis and hepatoblastoma is projected to rise. These findings highlight persistent regional, demographic, and etiological disparities and the need for targeted public health action.

iScienceVol. 29(7)
Sun Yat-sen University (CN), Shanghai Jiao Tong University (CN), Fudan University (CN), Renji Hospital (CN), Zhongshan Hospital (CN), The First Affiliated Hospital, Sun Yat-sen University (CN), Shanghai Institute of Hematology (CN)
Sanming Project of Medicine in Shenzhen
Openalex Percentile: Top 8%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Global landscape of liver disease burden in 1990–2021 — M Zhang, Weiqiu Jin, et al. · iScience (2026) | TGRS Research Map | TGRS